Havana,
Apr 26 (Prensa Latina) Measures applied in Cuba to contain the Covid-19
epidemic are paying off, according to the evaluation of scientists from the
island at a meeting with President Miguel Díaz-Canel.
Predictive
models on active cases show that Cuba has moved in recent days on the most
favorable scenario, it emerged from the meeting held the day before at the
Palace of the Revolution, in this capital.
However,
this cannot be a reason for demobilization, because the peak of the pandemic
has not yet arrived on the Island, experts warned.
The
website of the Presidency of the Republic reported on the meeting, in which it
was reaffirmed that the most critical moment must be reached 77 days after the
disease began progressing, which should occur by the end of May. A study on the
mobility of people after the implementation of social isolation was also
presented at the meeting, carried out by the Faculty of Physics of the
University of Havana.
As
explained by the doctor of science Alejandro Lage Castellano, the movement in
all provinces has been falling to about 50 percent, although in the previous
week it fell a little more.
This
was interpreted as a demonstration that mobility reduction measures are
working.
In
this regard, specialists from the Cuban Telecommunications Company explained
that these data on mobility are obtained through the use of cell phones.
For
this, they clarified, the identity of the people is not used; on the contrary,
massive or collective analyzes of the information are carried out, as is the
case throughout the world.
In
particular, clinical studies with the preventive use of Biomodulin T in all
nursing homes in the country were explained; and the use of the nasal
Interferon combined with Biomodulin T, in patients of Nursing Home No.3 in the
central city of Santa Clara, where an open transmission event of the new
coronavirus occurred.
Likewise,
the treatments of critically ill and critically ill patients with Cuban
anti-CD6 mAb products itolizumab and CIGB 258 were detailed, both with very
promising results in this type of patient.
